A model for next generation pharma & biotech program delivery

Among the radically changing technology landscape in the Life Sciences lies promise of safer, faster, and more efficient development of products. Biomarkers, personalized medicine and computer models are all showing signs of success. In conjunction with new operational strategies, the process of commercializing life altering therapies will radically evolve in the coming years.
Two of these operational strategies are the collaborative virtual model and the unencumbered flow of data from discipline and system to discipline and system. The problem is - how do you get these to approaches to work in harmony. The virtualized model requires outsourcing many if not most of the development functions. Outsourcing has the potential to create silos that interupt the flow of data and the interaction of people. These silos also blur the visibility of key decision makers.
Clearly the benefit of outsourcing is there. You get the expertise in the disciplines that you need when you need it and only when you need it. So how do you kill the silo effect?
The way have approached this problem is by opening up a common Program Delivery system that can be accessed by all contributors on the program or project. The sponsor doesn't worry about the incremental cost of external user licenses. Data is secure and access is controlled. No matter the phase or discipline whether clinical, stats, regulatory, legal, or any other contributor their content is stored centrally and their days can flow or me used for subsequent needs, like submissions.